You are here: Home Education Residency Program Current Residents Jay L. Patel, M.D.
Document Actions

Jay L. Patel, M.D. - Pathology Resident

last modified 2009-08-26 11:47 — by Amy Motta

Jay L. Patel, M.D.

Jay Patel, M.D.

Rank: PGY- 4

Residency Program: AP/CP

Contact Info

Email Address: Jay.Patel ((at)) hsc.utah.edu

Office Phone Number: 801-587-4281

Pager Number: 339-0006

Location:   University of Utah Hospital

Division: Residency Program

 

Professional Education

  • 2006, M.D. University of Arizona College of Medicine, Tucson, Arizona
  • 2002, B.S. Molecular and Cellular Biology, University of Arizona, Tucson, Arizona

Presentations

  • Aberrant Expression of T-Cell Antigens in Diffuse Large B-Cell Lymphoma of the Testis, Poster, College of American Pathologists (CAP) 2009 Annual Meeting, Washington D.C., October 12, 2009
  • Precursor T-Lymphoblastic Lymphoma in Children and Adolescents: An Immunophenotypic Analysis of a Large Cohort (N=186); A Children’s Oncology Group Report, Poster, Third International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin's Lymphoma, Frankfurt, Germany, June 12, 2009
  • Precursor T-Lymphoblastic Lymphoma: An Immunophenotypic Analysis of 186 Cases, Poster, 98th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, Boston, Massachusetts, March 11, 2009
  • Immunohistochemical expression of myeloid and monocytic markers in extramedullary myeloid tumors of the skin, Poster, 45th Annual Meeting of The American Society of Dermatopathology (ASDP), San Francisco, California, October 17, 2008
  • CYFRA 21-1 in a complementary tumor marker to carcinoembryonic antigen and squamous cell carcinoma antigen in non-small cell lung cancer patients, Poster, 43rd Annual Academy of Clincal Laboratory Physicians & Scientists (ACLPS) Meeting, Philadelphia, Pennsylvania, June 6, 2008
  • Radiation Biology and Cancer, Inhibition of Akt in Combination with Radiation Therapy: A Successful Strategy Depending on PTEN Activity in Human Glioblastoma, Poster, American Association for Cancer Research (AACR) Special Conference, February, 2002

Publications

  • Histopathologic Review of Previously Negative Prostatic Core Needle Layfield, LJ, Patel J. Biopsies Following a New Diagnosis of Adenocarcinoma of the Prostate by Core Needle Biopsies: Implications for Quality Assurance Programs. Clinical Medicine: Pathology, 16 Sep 2008, 2008:1 77-81
  • Stea B, Falsey R, Kislin K, Patel J, Glanzberg H, Carey S, Ambrad AA, Meuillet EJ, Martinez JD. Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 ('Iressa'). Cancer Lett. 2003 Dec 8;202(1):43-51.

About Jay L. Patel, M.D.

Jay enjoys traveling, gardening, betting on football and playing poker.  Jay is currently the Assistant Medical Director of the Automated Core Lab and an Assistant Medical Director of the Hematopoietic Flow Cytometry Lab at ARUP Laboratories, Inc.  Jay will begin the Hematopathology Fellowship at Stanford University in Palo Alto, California in July of 2010.